📰 Clinical Presentation News
Page 2 - Clinical Presentation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Presentation. Real-time updates on events, politics, business and more.
June 25, 2023
Syringomyelia or hydromyelia is a rare neurological disorder where the person develops a fluid-filled cavity called syrinx in the spinal cord. Symptoms, diagnosis, treatment of syringomyelia are explained in detail.
June 20, 2023
Neonatal hepatitis is an inflammation of the liver that usually occurs in early infancy and is typically transmitted to the baby by the infected mother.
June 15, 2023
/PRNewswire/ -- The "PEComa - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.coms offering. This report delivers an in-depth...
May 12, 2023
Sulbactam-durlobactam is the first pathogen-targeted therapy under investigation for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by... | May 11, 2023
May 12, 2023
Sulbactam-durlobactam is the first pathogen-targeted therapy under investigation for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex (Acinetobacter).WALTHAM, Mass.--(BUSINESS WIRE)--Inn...
April 17, 2023
New Drug Application for sulbactam-durlobactam for the treatment of adults with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible strains of... | April 17, 2023
March 14, 2023
BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and other healthcare assets, today announced that the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee will convene April 17, 2023 to review dat...
February 3, 2023
/PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced plans to present detailed results from the registrational PIONEER trial of...
January 9, 2023
Primary endpoint at week 16 was met for all three active doses of oral orismilast in moderate to severe patients with psoriasis. Statistical significance...
December 13, 2022
Treatment Outcome and Associated Factors Among Patients Admitted with Hypertensive Crisis in Public Hospitals at Harar Town, Eastern Ethiopia: A Cross-Sectional Study